Shl Telemedicine (SHLTN) Stock Statistics & Valuation Metrics

Shl Telemedicine has a market cap or net worth of CHF38.91M. The enterprise value is CHF42.04M.

Shl Telemedicine has 37,059,944 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shl Telemedicine’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -7.90%.

The current PE Ratio of Shl Telemedicine is ―. Shl Telemedicine’s PEG ratio is 0.04.

In the last 12 months, Shl Telemedicine had revenue of 61.49M and earned -16.11M in profits. Earnings per share was -0.76.

In the last 12 months, operating cash flow was -1.64M and capital expenditures -1.46M, giving a free cash flow of -3.10M billion.

Shl Telemedicine pays an annual dividend of ―, resulting in a dividend yield of ―

Shl Telemedicine upcoming earnings date is Apr 15, 2026, TBA (Confirmed).

Shl Telemedicine as a current ratio of 1.25, with Debt / Equity ratio of 41.07%

In the past 12 months, Shl Telemedicine has paid 927.10K in taxes.

Shl Telemedicine EV to EBITDA ratio is 6.01, with an EV/FCF ratio of -5.67.

Shl Telemedicine has CHF25.26M in cash and marketable securities with CHF13.08M in debt, giving a net cash position of CHF12.18M billion.

Gross margin is 45.43%, with operating margin of -7.69%, and net profit margin of -26.20%.

The average price target for Shl Telemedicine is ―, which is 11.43% higher than the current price. The consensus rating is ―